Figure 2.
Figure 2. Antifungal therapy of invasive aspergillosis in myelosuppressed and immunosuppressed cancer patients. Clinical response to primary therapy. / Abbreviations: dAMB, amphotericin B deoxycholate; ABCD, amphotericin B colloidal dispersion; ABLC, amphotericin B lipid complex; L-AMB, liposomal amphotericin B; ITR, itraconazole; VOR, voriconazole.

Antifungal therapy of invasive aspergillosis in myelosuppressed and immunosuppressed cancer patients. Clinical response to primary therapy.

Abbreviations: dAMB, amphotericin B deoxycholate; ABCD, amphotericin B colloidal dispersion; ABLC, amphotericin B lipid complex; L-AMB, liposomal amphotericin B; ITR, itraconazole; VOR, voriconazole.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal